Initial Workup and Treatment for Loss of Libido and Vaginal Dryness in Females
The initial workup for female patients with loss of libido and vaginal dryness should include assessment of reversible contributing factors, followed by treatment with nonhormonal water-based lubricants and moisturizers for vaginal dryness, while addressing psychological factors through appropriate counseling. 1
Comprehensive Assessment
Medical History
Assess for signs and symptoms of sexual dysfunction:
- Decreased libido (affects 23-64% of patients)
- Vaginal dryness and lubrication concerns (20-48%)
- Dyspareunia (35-38%)
- Orgasmic difficulties (16-36%) 1
Identify potential contributing factors:
- Medications that affect sexual function
- Hormonal status (menopausal, post-chemotherapy)
- History of cancer treatments (especially breast cancer)
- Psychological factors (depression, anxiety, stress)
- Relationship issues 1
Physical Examination
- Evaluate for:
- Vaginal atrophy
- Vaginal abrasions or inflammation
- Signs of infection
- Pelvic floor dysfunction 1
Treatment Algorithm
First-Line Treatment for Vaginal Dryness
- Nonhormonal treatments:
- Water-based lubricants for intercourse
- Vaginal moisturizers for ongoing relief
- Silicone-based products (may last longer than water-based products)
- Consider combination therapy for enhanced comfort 1
For Persistent Symptoms
Consider vaginal dilators or pelvic floor relaxation techniques for dyspareunia secondary to vaginal atrophy and stenosis 1
For refractory cases only:
- Low-dose vaginal estrogen may be considered (tablets or ring)
- Note: Safety in breast cancer patients is not well established
- Contraindicated in women on aromatase inhibitors 1
For Decreased Libido
Address psychological factors:
- Refer for psychoeducational support
- Sexual counseling
- Marital counseling when appropriate
- Group therapy 1
Treat associated symptoms that may affect libido:
- For vasomotor symptoms (hot flashes): Consider SNRIs, SSRIs, or gabapentin
- For mood disorders: Appropriate psychiatric treatment 1
Important Considerations and Pitfalls
Cautions
- Hormonal therapies have variable absorption levels and should be used with caution
- Systemic hormone therapy is rarely recommended, especially in patients with history of breast cancer 1
- When using SSRIs in patients on tamoxifen, avoid paroxetine due to CYP2D6 inhibition 1
Common Pitfalls to Avoid
Neglecting to assess for sexual dysfunction: Up to 76% of women experience sexual complaints, but these are often overlooked in clinical practice 2
Assuming age is a barrier to sexuality: Frailty and age alone should not prevent addressing sexual health concerns 3
Focusing only on physical symptoms: Sexual dysfunction often has psychological components that require addressing 1
Delaying treatment: Early intervention with nonhormonal options can prevent worsening of symptoms and improve quality of life 4, 5
Missing underlying medical conditions: Diabetes and other chronic conditions can contribute to sexual dysfunction and should be optimally managed 6
By following this approach, clinicians can effectively address both the physical and psychological aspects of decreased libido and vaginal dryness, improving quality of life and sexual function in female patients.